The Capital Partnership

Supira Medical, Inc. is a medical device company that specializes in developing a percutaneous ventricular assist device (pVAD) aimed at high-risk patients undergoing interventional procedures. This innovative device provides temporary mechanical support to assist the heart's native pumping action, making it a critical solution for patients facing severe coronary artery disease or cardiogenic shock during coronary interventions. The company's technology is designed to facilitate recovery in patients who require urgent mechanical support, thereby enhancing their ability to undergo necessary medical procedures. Founded in 2012 and based in Campbell, California, Supira Medical was previously known as Lumenblation Medical, Inc. before rebranding in March 2016.

Laza Medical is a privately held startup that specializes in the development of AI-powered robotic imaging solutions for cardiovascular treatments. The company aims to enhance the quality of imaging in cardiac interventions by integrating advanced artificial intelligence software with robotic technology. This innovative approach is designed to optimize procedural workflows and improve the standard of imaging for cardiovascular procedures. By providing a user-friendly interface, Laza Medical seeks to make high-quality imaging and advanced procedural navigation accessible to a wide range of clinicians, ultimately enhancing patient care in the field of cardiovascular medicine.

Supira Medical, Inc. is a medical device company that specializes in developing a percutaneous ventricular assist device (pVAD) aimed at high-risk patients undergoing interventional procedures. This innovative device provides temporary mechanical support to assist the heart's native pumping action, making it a critical solution for patients facing severe coronary artery disease or cardiogenic shock during coronary interventions. The company's technology is designed to facilitate recovery in patients who require urgent mechanical support, thereby enhancing their ability to undergo necessary medical procedures. Founded in 2012 and based in Campbell, California, Supira Medical was previously known as Lumenblation Medical, Inc. before rebranding in March 2016.

Akura Medical is focused on developing innovative medical devices aimed at improving the process of thrombectomy, specifically through a next-generation device designed for easy use in a single-pass procedure to efficiently remove blood clots. The company specializes in thrombectomy devices and also offers a range of surgical, medical, dental, and veterinary instruments. By providing effective solutions for clot removal, Akura Medical enables healthcare professionals to better address critical needs and treat venous thromboembolism of varying sizes.

Myra Vision is engaged in developing innovative treatment solutions for patients suffering from moderate to severe glaucoma. The company focuses on surgical techniques that effectively reduce intraocular pressure (IOP), addressing significant gaps in existing therapies. By providing a platform that minimizes the risk of hypotony, Myra Vision aims to enhance treatment options for physicians and improve patient outcomes in managing glaucoma.

Tioga Cardiovascular is a privately held company under Shifamed LLC, specializing in the development of medical devices for valve replacement in mitral and tricuspid applications. The company is dedicated to creating innovative solutions that simplify procedures and utilize less invasive, transcatheter techniques. By focusing on elegant design and functionality, Tioga Cardiovascular aims to enhance the effectiveness and success of heart surgeries, providing healthcare professionals with advanced tools for treating patients with valvular heart diseases.

Atia Vision, Inc. is a medical device company based in Campbell, California, specializing in the development of innovative solutions for eye care. Founded in 2012, the company focuses on creating modular presbyopia-correcting intraocular lenses that address the needs of the intraocular lens replacement market. Atia Vision's technology mimics the natural accommodation of the eye by utilizing the ciliary muscles, which allows for a full range of functional vision restoration for cataract patients. The accommodating intraocular lenses are designed to provide effective vision correction without the need for glasses, thereby improving patient outcomes and enhancing the overall quality of life for individuals with vision impairment.

Adona Medical is a privately held company focused on developing innovative interventional solutions for heart failure, a condition that affects around 6.5 million patients in the United States and approximately 26 million worldwide. The company's heart failure management system is designed for personalized care, utilizing advanced sensor and shunt technologies to enhance the standard of heart care. By implementing interatrial shunt technology, Adona Medical aims to improve the understanding of a patient's hemodynamic status, allowing healthcare providers to tailor treatments to individual needs and ultimately enhance patient outcomes in managing heart failure.

Supira Medical, Inc. is a medical device company that specializes in developing a percutaneous ventricular assist device (pVAD) aimed at high-risk patients undergoing interventional procedures. This innovative device provides temporary mechanical support to assist the heart's native pumping action, making it a critical solution for patients facing severe coronary artery disease or cardiogenic shock during coronary interventions. The company's technology is designed to facilitate recovery in patients who require urgent mechanical support, thereby enhancing their ability to undergo necessary medical procedures. Founded in 2012 and based in Campbell, California, Supira Medical was previously known as Lumenblation Medical, Inc. before rebranding in March 2016.

Mindstep is a developer of cognitive and mental health digital therapeutics aimed at reducing the risk of dementia. Founded by medical professionals, the company prioritizes accessibility, empathy, and scientific rigor in delivering effective care. Its innovative platform leverages machine learning and clinical research to create digital solutions that allow users to conduct self-screenings for dementia, thereby overcoming limitations in traditional healthcare access. By providing a virtual clinic experience, Mindstep seeks to empower individuals with tools for better mental health management and improved cognitive outcomes.

Akura Medical is focused on developing innovative medical devices aimed at improving the process of thrombectomy, specifically through a next-generation device designed for easy use in a single-pass procedure to efficiently remove blood clots. The company specializes in thrombectomy devices and also offers a range of surgical, medical, dental, and veterinary instruments. By providing effective solutions for clot removal, Akura Medical enables healthcare professionals to better address critical needs and treat venous thromboembolism of varying sizes.

Elemy is a nationwide provider of childhood behavioral and mental healthcare, specializing in areas such as autism, ADHD, OCD, depression, social anxiety, and bipolar disorder. Launched in April 2020, the company utilizes a technology-driven care model that modernizes traditional healthcare delivery through in-home services. This approach enhances access to care, improves clinical outcomes, and reduces costs. Elemy's platform offers free autism assessments and matches children with therapists to develop individualized treatment plans tailored to their specific needs. The multidisciplinary clinical team implements an integrated treatment model that has demonstrated significant improvements in behavior. Backed by notable venture capital and healthcare investors, Elemy is committed to transforming the landscape of childhood mental health care.

Tioga Cardiovascular is a privately held company under Shifamed LLC, specializing in the development of medical devices for valve replacement in mitral and tricuspid applications. The company is dedicated to creating innovative solutions that simplify procedures and utilize less invasive, transcatheter techniques. By focusing on elegant design and functionality, Tioga Cardiovascular aims to enhance the effectiveness and success of heart surgeries, providing healthcare professionals with advanced tools for treating patients with valvular heart diseases.

Myra Vision is engaged in developing innovative treatment solutions for patients suffering from moderate to severe glaucoma. The company focuses on surgical techniques that effectively reduce intraocular pressure (IOP), addressing significant gaps in existing therapies. By providing a platform that minimizes the risk of hypotony, Myra Vision aims to enhance treatment options for physicians and improve patient outcomes in managing glaucoma.

Myra Vision is engaged in developing innovative treatment solutions for patients suffering from moderate to severe glaucoma. The company focuses on surgical techniques that effectively reduce intraocular pressure (IOP), addressing significant gaps in existing therapies. By providing a platform that minimizes the risk of hypotony, Myra Vision aims to enhance treatment options for physicians and improve patient outcomes in managing glaucoma.

Collective Health is a prominent health benefits platform that streamlines the management of medical, dental, vision, and pharmacy services for employees and their families. By offering an integrated solution through a cloud-based self-insurance platform, the company simplifies the administration of health plans via a single portal. This platform provides users with clear guidance, live concierge support, and digital tools to facilitate the navigation and management of healthcare services. Collective Health aims to reduce the complexities of delivering health benefits, enhance the member experience, and promote healthier outcomes for both employees and organizations. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.

Supira Medical, Inc. is a medical device company that specializes in developing a percutaneous ventricular assist device (pVAD) aimed at high-risk patients undergoing interventional procedures. This innovative device provides temporary mechanical support to assist the heart's native pumping action, making it a critical solution for patients facing severe coronary artery disease or cardiogenic shock during coronary interventions. The company's technology is designed to facilitate recovery in patients who require urgent mechanical support, thereby enhancing their ability to undergo necessary medical procedures. Founded in 2012 and based in Campbell, California, Supira Medical was previously known as Lumenblation Medical, Inc. before rebranding in March 2016.

CloudCath is a company that specializes in developing a remote monitoring platform for peritoneal dialysis patients. Their innovative system utilizes sensor-enabled technology to provide continuous monitoring, allowing for early detection of complications associated with catheter-based treatments. By leveraging Internet of Things (IoT) capabilities, CloudCath's platform enables healthcare providers to remotely oversee patients during their home treatment, significantly reducing the frequency of in-person visits. This approach not only enhances patient safety but also improves the overall management of care for individuals undergoing peritoneal dialysis, ultimately promoting better health outcomes.

Palantir Technologies Inc. is a data analytics company that provides software solutions for integrating, visualizing, and analyzing large and complex data sets. Founded in 2003 and headquartered in Palo Alto, California, Palantir offers two primary platforms: Palantir Gotham, which supports government organizations in managing and analyzing data, and Palantir Foundry, which serves commercial enterprises. The company's software enables organizations across various sectors—including government, defense, finance, healthcare, and non-profits—to collaborate and derive insights from vast amounts of information. Palantir’s solutions address a range of applications, including anti-fraud efforts, crisis response, cybersecurity, and healthcare delivery. The company has established strategic partnerships, such as with United Airlines, to enhance its service offerings.

Atia Vision, Inc. is a medical device company based in Campbell, California, specializing in the development of innovative solutions for eye care. Founded in 2012, the company focuses on creating modular presbyopia-correcting intraocular lenses that address the needs of the intraocular lens replacement market. Atia Vision's technology mimics the natural accommodation of the eye by utilizing the ciliary muscles, which allows for a full range of functional vision restoration for cataract patients. The accommodating intraocular lenses are designed to provide effective vision correction without the need for glasses, thereby improving patient outcomes and enhancing the overall quality of life for individuals with vision impairment.

Tioga Cardiovascular is a privately held company under Shifamed LLC, specializing in the development of medical devices for valve replacement in mitral and tricuspid applications. The company is dedicated to creating innovative solutions that simplify procedures and utilize less invasive, transcatheter techniques. By focusing on elegant design and functionality, Tioga Cardiovascular aims to enhance the effectiveness and success of heart surgeries, providing healthcare professionals with advanced tools for treating patients with valvular heart diseases.

NuVera Medical, Inc. is a privately held company based in Campbell, California, specializing in the development of an innovative imaging platform designed for complex cardiovascular procedures. Established in 2016, the company utilizes advanced 4D ultrasound technology to enhance intracardiac echocardiography. This platform enables healthcare specialists, particularly cardiologists, to perform transcatheter cardiac interventions by providing real-time visualization of heart chambers. This capability supports informed decision-making during procedures, ultimately aiming to improve patient outcomes in cardiovascular care. NuVera Medical operates under the portfolio of Shifamed, LLC.

Uber is a technology company that revolutionizes transportation by connecting riders with drivers through its mobile application. Founded in 2009 and headquartered in the United States, Uber operates in over 300 cities globally, making urban travel more accessible. The platform allows users to submit trip requests, which are efficiently routed to available drivers, thus enhancing the convenience of transportation. In addition to its core ridesharing services, Uber is also investing in advanced technologies, including autonomous vehicles through its subsidiary, Uber Advanced Technologies Group. This division aims to develop safe and reliable self-driving transportation solutions. Furthermore, Uber Elevate is working to establish the framework for aerial ridesharing, collaborating with various stakeholders to envision the future of air travel. Through these initiatives, Uber continues to expand its service offerings and redefine mobility in urban environments.

Atia Vision, Inc. is a medical device company based in Campbell, California, specializing in the development of innovative solutions for eye care. Founded in 2012, the company focuses on creating modular presbyopia-correcting intraocular lenses that address the needs of the intraocular lens replacement market. Atia Vision's technology mimics the natural accommodation of the eye by utilizing the ciliary muscles, which allows for a full range of functional vision restoration for cataract patients. The accommodating intraocular lenses are designed to provide effective vision correction without the need for glasses, thereby improving patient outcomes and enhancing the overall quality of life for individuals with vision impairment.

Supira Medical, Inc. is a medical device company that specializes in developing a percutaneous ventricular assist device (pVAD) aimed at high-risk patients undergoing interventional procedures. This innovative device provides temporary mechanical support to assist the heart's native pumping action, making it a critical solution for patients facing severe coronary artery disease or cardiogenic shock during coronary interventions. The company's technology is designed to facilitate recovery in patients who require urgent mechanical support, thereby enhancing their ability to undergo necessary medical procedures. Founded in 2012 and based in Campbell, California, Supira Medical was previously known as Lumenblation Medical, Inc. before rebranding in March 2016.

NuVera Medical, Inc. is a privately held company based in Campbell, California, specializing in the development of an innovative imaging platform designed for complex cardiovascular procedures. Established in 2016, the company utilizes advanced 4D ultrasound technology to enhance intracardiac echocardiography. This platform enables healthcare specialists, particularly cardiologists, to perform transcatheter cardiac interventions by providing real-time visualization of heart chambers. This capability supports informed decision-making during procedures, ultimately aiming to improve patient outcomes in cardiovascular care. NuVera Medical operates under the portfolio of Shifamed, LLC.

Cerestra is a private equity firm that specializes in investing in real estate assets that are socially relevant and critical for business. The firm focuses on sectors such as K-12 education infrastructure, student housing, life sciences real estate, and industrial light manufacturing facilities. By providing a platform for innovative and risk-mitigated investment opportunities, Cerestra aims to create a unique investment landscape that fosters strong relationships and proprietary strategies. Through its targeted approach, the firm seeks to address essential needs within these sectors while delivering value to its investors.

Northgate Mexico, established in 2014, is a fund of funds managed by Northgate Capital, which is headquartered in the United States with an affiliate office in Mexico City. This fund primarily focuses on investments in the software and technology, media, and telecommunications (TMT) sectors across North America. Northgate Capital, founded in 2000, operates a range of investment programs including venture capital and private equity, managing a total of $4.8 billion in assets. The firm employs over 50 investment and finance professionals globally, with a commitment to fostering growth in various sectors through strategic investments.